# FDA recall D-0327-2024

> **Amneal Pharmaceuticals of New York, LLC** · Class II · drug recall initiated 2024-02-13.

## Product

Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6

## Reason for recall

Failed Impurities/Degradation Specifications: Out-of-specification test results.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0327-2024
- **Recalling firm:** Amneal Pharmaceuticals of New York, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2024-02-13
- **Report date:** 2024-02-28
- **Termination date:** 2025-02-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Brookhaven, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0327-2024

## Citation

> MORVS. FDA recall D-0327-2024. Retrieved 2026-10-16 from https://api.morvs.ai/recall/D-0327-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*